EPS for Senseonics Holdings, Inc. (SENS) Expected At $-0.16

October 2, 2018 - By Darrin Black

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) Logo

Analysts expect Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) to report $-0.16 EPS on October, 30.They anticipate $0.03 EPS change or 23.08 % from last quarter’s $-0.13 EPS. After having $-0.16 EPS previously, Senseonics Holdings, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 2.75% or $0.125 during the last trading session, reaching $4.415. About 1.02 million shares traded. Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) has risen 50.33% since October 2, 2017 and is uptrending. It has outperformed by 34.71% the S&P500.

Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe. The company has market cap of $777.16 million. The Company’s product includes Eversense, a first generation continuous glucose monitoring system, which measures glucose levels in people with diabetes for a period of up to 90 days. It currently has negative earnings. The firm has a research and development license agreement with TypeZero Technologies, Inc. to develop artificial pancreas and decision support systems that use the Eversense continuous glucose monitoring system.

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News